Cytori Therapeutics has obtained approval from the Health Sciences Authority (HSA) in Singapore for the Celution system, designed for autologous re-implantation or re-infusion of a patient’s own adipose-derived regenerative cells ...
Tags: Celution System, Medicine
Cytori Therapeutics, a developer of cell therapies based on autologous adipose-derived regenerative cells (ADRCs), has obtained Russian approval for its Celution 800 system. The Celution system and its related products including ADRCs ...
Tags: cell therapy, Celution 800 system, clinical product, clinical research
Cytori Therapeutics has treated first US patient in the ATHENA trial using the company's cell therapy based on patient's own adipose-derived stem and regenerative cells (ADRCs). ADRCs are processed using the company's proprietary Celution ...